C O M M U N I C A T I O N S
From these studies, we selected a 1:1 mixture of tert-BuOH/H2O
for reasons of substrate solubility and reactivity. At higher
concentrations (0.5 M), the reactions were done within minutes and
proceeded with visible loss of carbon dioxide. The isoxazolidines
also coupled with R-ketoacids at room temperature with syntheti-
cally useful reaction rates (entry 7).
The ketoester products could be directly converted to the
corresponding carboxylic acids by oxidative decarboxylation in the
presence of basic hydrogen peroxide (eq 3).
The amide formation is chemoselective. Unprotected glutamic
acid substrate 8 reacted cleanly with pyruvic acid to give amino
acid derivative 9 in excellent yield (eq 1). In the context of solution
phase synthesis, reactions with unprotected amines were most
conveniently performed in MeOH, which upon removal of the
solvent afforded the corresponding amide-acetals (eq 2).
The ketoacid-hydroxylamine peptide ligation uses a unique set
of functional groups to achieve chemoselective amide bond forma-
tion in the presence of unprotected functionalities and without re-
agents. Further applications, including the identification of new mono-
mers suitable for other amide-based targets, will contribute to new
methods for the preparation of peptidic structures and materials.
Acknowledgment. This work was supported by the University
of California, a Camille and Henry Dreyfus New Faculty Award
(to J.W.B.), the donors of the Petroleum Research Fund (admin-
istered by the American Chemical Society), and the Society of
Japanese Pharmacopeia. E.A.D. was a 2005 Pfizer AIR Minority
Summer Fellow. We are grateful to Chris Day and Kenneth Chow
for preliminary studies.
The products of the reaction of isoxazolidines with ketoacids
were methyl R-ketoesters, which were easily saponified to R-ke-
toacids, and the peptide chain was extended by reaction with another
isoxazolidine (Scheme 1). This two-step iteration could be carried
out without purification or isolation of the intermediate acid. Using
this approach, we have prepared a number of di- and tripeptides
(Table 2). While there are some decreases in coupling rates as larger
molecules and lower concentrations are used, in all cases, the pep-
tide couplings proceed cleanly. For preliminary studies, we em-
ployed side-chain-protected substrates and isolated the intermediate
peptides. Less than optimal yields for some substrates, especially
those containing âh-valine residues, reflect the insolubility of the
â-oligopeptides during workup and silica gel chromatography and
not limitations of the amide formation step. Further studies employ-
ing solid phase synthesis and optimization of protocols for multiple,
iterative couplings without isolating intermediates are in progress.
Supporting Information Available: Experimental procedures and
characterization data for all compounds. This material is available free
References
(1) (a) Cheng, P. R.; Gellman, S. H.; DeGrado, W. F. Chem. ReV. 2001, 101,
3219. (b) Seebach, D.; Beck, A. K.; Bierbaum, D. J. Chem. BiodiV. 2004,
1, 1111-1239.
(2) (a) Rueping, M.; Mahajan, Y.; Sauer, M.; Seebach, D. ChemBioChem
2002, 257-259. (b) Umezawa, N.; Gelman, M. A.; Haigis, M. C.; Raines,
R. T.; Gellman, S. H. J. Am. Chem. Soc. 2002, 124, 368-369.
(3) (a) Porter, E. A.; Wang, X.; Lee, D.; Weisblum, B.; Gellman, S. H. Nature
2000, 123, 565-565. (b) Arvidsson, P. I.; Ryder, N. S.; Weiss, H. M.;
Hook, D. F.; Escalante, J.; Seebach, D. Chem. BiodiV. 2005, 2, 401-
420.
Table 2. Selected â-Oligopeptides Prepared by Isoxazolidine
Couplings (see Scheme 1)
(4) Seebach, D.; Rueping, M.; Arvidsson, P. I.; Kimmerlin, T.; Micuch, P.;
Noti, C.; Langenegger, D.; Hoyer, D. HelV. Chim. Acta 2001, 84, 3503-
3510.
(5) (a) Kritzer, J. A.; Lear, J. D.; Hodsdon, M. E.; Schepartz, A. J. Am. Chem.
Soc. 2004, 126, 9468-9469. (b) Sadowsky, J. D.; Schmitt, M. A.; Lee,
H.-S.; Umezawa, N.; Wang, S.; Tomita, Y.; Gellman, S. H. J. Am. Chem.
Soc. 2005, 127, 11966-11968. (c) Werder, M.; Hauser, H.; Abele, S.
Seebach, D. HelV. Chim. Acta 1999, 82, 1774-1783.
(6) Murray, J. K.; Gellman, S. H. Org. Lett. 2005, 7, 1517-1520.
(7) Arvidsson, P. I.; Frackenpohl, J.; Seebach, D. HelV. Chim. Acta 2003,
86, 1522-1553.
(8) Steer, D. L.; Lew, R. A.; Perlmutter, P.; Smith, A. I.; Aguilar, M. I. Curr.
Med. Chem. 2002, 9, 811-822.
(9) Bode, J. W.; Fox, R. M.; Baucom, K. D. Angew. Chem., Int. Ed. in press.
dx.doi.org/10.1002/anie.200503991.
(10) Vasella, A. HelV. Chim. Acta 1977, 60, 1273-1295.
(11) For other recent applications of carbohydrate-derived chiral auxiliaries
for the synthesis of hydroxylamines and isoxazolidines, see: (a) Fa¨ssler,
R.; Frantz, D. E.; Oetiker, J.; Carreira, E. M. Angew. Chem., Int. Ed. 2002,
41, 3054-3056. (b) Kasahara, K. Iida, H.; Kibayashi, C. J. Org. Chem.
1989, 54, 2225-2233.
(12) For other practical approaches to enantioenriched isoxazolidines, see: (a)
Fuller, A. A.; Chen, B.; Miner, A. R.; Mapp, A. K. J. Am. Chem. Soc.
2005, 127, 5376-5383. (b) Sibi, M. P.; Prabagaran, N.; Ghorpade, S. G.;
Jasperse, C. P. J. Am. Chem. Soc. 2003, 125, 11796-11797.
(13) Enantiomeric purities and absolute configurations were confirmed by
conversion to known compounds and by chiral HPLC studies.
(14) For this study, we utilized a D-mannose-derived chiral auxiliary that
afforded the “unnatural” peptide enantiomers. We have also prepared the
“natural” enantiomers by using a chiral auxiliary derived from D-gulose.
Further studies on the syntheses of these and other isoxazolidine monomers
will be reported separately.
a Overall yield of pure, isolated product for (i) ketoester hydrolysis, (ii)
isoxazolidine coupling, and (iii) purification. See Supporting Information
for details.
JA057706J
9
J. AM. CHEM. SOC. VOL. 128, NO. 5, 2006 1453